22NW, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001694297

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedConsumer TiltHigh Turnover how tags are computed

Q2 2026 · 14 positions · Total reported value $104.68M · Top-10 concentration 94.6% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.9% · 4 new · 0 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.6% · vs SPY -3.8% · Prev Value $104.68M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.3% · vs SPY -3.4% · Latest Value $144.32M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, 22NW, LP disclosed 14 equity positions with a combined reported value of $104.68M. The filing implies a focused portfolio: its ten largest positions account for 94.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Consumer Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were NSP ($20.37M), NKTR ($19.62M), SRI ($18.06M). By sector, the heaviest allocations are Consumer Discretionary 59.9%, Health Care 33.8%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+27.5pp) and away from Financials (-1.2pp), Other (-1.7pp).

Versus the prior quarter, 22NW, LP opened 4 new positions, trimmed 0 and fully exited 3, a turnover rate of 38.9% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q2 2026 were TBCH ($179.65K).

Of the 3 positions fully exited versus the prior quarter, the largest were FSTR ($29.77M), FARM ($2.48M), PFX ($1.68M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • TBCH TURTLE BEACH CORP · $179.65K

Fully Exited (vs previous quarter)

  • FSTR FOSTER L B CO · prev qtr: $29.77M
  • FARM FARMER BROS CO · prev qtr: $2.48M
  • PFX PHENIXFIN CORP · prev qtr: $1.68M

Insider Transactions (Form 4)

Latest 22NW, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

22NW LP, based in Seattle, WA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 14 positions worth $104.68M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SEATTLE, WA, United States
  • SEC registration: 801-110797 (status: Approved), registered 2017-07-25
  • Regulatory AUM (Form ADV): $295.59M as of 2026-03-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: englishcap.com

Portfolio Structure

  • 14 positions · $104.68M reported value (Q2 2026)
  • Top 10 holdings = 94.6% of reported value
  • Largest position: NSP (INSPERITY INC) at 19.5%
  • Average position size: $7.48M

Sector Tilt

  • Consumer Discretionary 59.9%
  • Health Care 33.8%
  • Industrials 6.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 1 added, 1 reduced, 3 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a cautious stance, with a slight preference for healthcare and consumer discretionary sectors. The lack of significant changes in holdings suggests a conservative approach to market volatility. 2. Key Moves: - Added: Core Molding Technologies (CMT) with a 22.8% increase in shares. - Reduced: Mineralys Therapeutics (MLYS) by 74.4% in shares. - No Change: The fund held steady in its other positions, with no additions or reductions. 3. Portfolio Structure: - Passive/Active: The fund seems to lean towards a passive approach, as indicated by the "Hold" actions on most positions. - Sector Bias: The portfolio is biased towards healthcare and consumer discretionary sectors, with 34.29% of the total value in these sectors. - Risk Appetite: The fund exhibits a moderate risk appetite, with a balanced distribution across sectors and minimal changes in holdings. 4. Per-Holding One-Liner: - NSP: Insperity Inc., a provider of human resources and business solutions. - NKTR: Nektar Therapeutics, a biopharmaceutical company. - SRI: Stoneridge Inc., a designer and manufacturer of engineered systems for the automotive and trucking industries. - FOXF: Fox Factory Holdings Corp, a designer, manufacturer, and marketer of powersports accessories. - CMT: Core Molding Technologies, a designer and manufacturer of thermoplastic and thermoset composite components. - RGNX: Regeneron Pharmaceuticals Inc., a biopharmaceutical company. - CULP: Culp Inc., a manufacturer of woven and nonwoven fabrics. - RZLT: Rezulte Inc., a biopharmaceutical company. - UFI: Unifi Inc., a vertically integrated textile company. - MLYS: Mineralys Therapeutics Inc., a biopharmaceutical company. (unverified) 5. One-Sentence Style Summary: The fund maintained a conservative, sector-diversified approach with a slight tilt towards healthcare and consumer discretionary, with minimal changes in holdings, reflecting a cautious stance towards market dynamics.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 33.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 493.00K $20.37M 19.45%
19.45%
Hold
2 281.12K $19.62M 18.75%
18.75%
Hold
3 2.47M $18.06M 17.25%
17.25%
Hold
4 678.16K $11.49M 10.98%
10.98%
Hold
5 273.52K $6.46M 6.17%
6.17%
Add
6 492.76K $5.90M 5.64%
5.64%
Hold
7 1.86M $5.76M 5.50%
5.50%
Hold
8 820.65K $4.27M 4.08%
4.08%
Hold
9 852.46K $4.05M 3.87%
3.87%
Hold
10 113.84K $3.07M 2.93%
2.93%
Reduce
11 170.19K $2.94M 2.81%
2.81%
Hold
12 636.36K $2.51M 2.40%
2.40%
Hold
13 14.43K $179.65K 0.17%
0.17%
New
14 1.25K $6.22K 0.01%
0.01%
Hold

FAQ

What did 22NW, LP buy in 2026-Q2?

In its 2026-Q2 13F filing, 22NW, LP reported 14 equity positions worth $104.68M in aggregate; its largest disclosed positions were NSP ($20.37M), NKTR ($19.62M), SRI ($18.06M).

How large is 22NW, LP's portfolio?

22NW, LP reported $104.68M of long equity holdings across 14 positions as of 2026-Q2. Top-10 holdings account for 94.6% of reported value.

What is 22NW, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Consumer Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/22nw/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →